Bruno Marques, Remote - Live with Q&AHead of Process & Product Development at Century Therapeutics
Bruno Marques leads the Process & Product Development team at Century Therapeutics, with a focus on genetically engineered, universal iPSC-derived immune effector cell products (NK, T cells) to target hematologic and solid tumor cancers. Prior to Century, Bruno spent 14 years developing and commercializing biopharmaceutical products at Merck and GlaxoSmithKline, while directing biotechnology industry-related courses at Rutgers University. At GSK, Bruno held leadership roles in process development and portfolio management, contributing to the launch of drugs such as Nucala (mepolizumab). He eventually joined GSK’s Cell & Gene Therapy platform to support autologous immunotherapies as Director of Manufacturing Strategy. Bruno is a Chemical Engineer by training, with a PhD from Carnegie Mellon University and a BS from the Illinois Institute of Technology.